Trials / Active Not Recruiting
Active Not RecruitingNCT06565650
A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.
A Randomized, Multicenter, Double-Masked, Saline-Controlled Trial to Evaluate Corneal Endothelial Cell Density in Subjects With Dry Eye Disease Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 216 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Multicenter, Double-Masked, Saline-Controlled Trial to Evaluate Corneal Endothelial Cell Density in Subjects With Dry Eye Disease Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Miebo | 100% perfluorohexyloctane |
| DRUG | Saline | 0.6% sodium chloride solution |
Timeline
- Start date
- 2024-07-31
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
- First posted
- 2024-08-22
- Last updated
- 2024-12-17
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06565650. Inclusion in this directory is not an endorsement.